Independent UK medicine guidance
Mounjaro and anhedonia: why some people feel flat, and what the evidence says
Anhedonia means finding less pleasure in things you used to enjoy. Some people using Mounjaro (tirzepatide) describe a flat, muted feeling: food stops being a source of pleasure, and sometimes other things feel duller too. Anhedonia and low mood are not listed as side effects in the UK Mounjaro leaflet, and UK and European regulators found no causal link between GLP-1 medicines and depression or suicidal thoughts. That does not make what you feel any less real. This guide sets out possible explanations, what to track, and when to get help.
Key facts
- Low mood, anhedonia and depression are not listed as side effects in the UK Mounjaro patient leaflet or Summary of Product Characteristics.[1],[2]
- The MHRA concluded in September 2024 that the available evidence does not establish a causal relationship between GLP-1 receptor agonists and depression, suicidal thoughts or self-harm, in line with the European Medicines Agency review of April 2024.[3],[4] Those reviews covered semaglutide, liraglutide and related medicines rather than tirzepatide specifically, and the MHRA said it would keep monitoring.
- Feeling flat can have several plausible explanations that are not the medicine acting directly on your mood: losing food as a comfort, eating too little, tiredness, poor sleep, and the sheer size of the life change.
- Fatigue is a recognised Mounjaro side effect and can look and feel like low mood.[1]
- Red flag: if you have thoughts of harming yourself, this is urgent whatever the cause. See the help section below.
What people describe
The word people reach for most often is flat. Meals that used to be the highlight of the day become fuel. A favourite takeaway or a glass of wine does nothing. Some people say the dullness stops at food; others say it spreads, so that hobbies, socialising or sex feel less rewarding than before. A few say the opposite, that losing the constant pull towards food has lifted their mood.
None of these experiences is wrong, and a webpage cannot tell you which one you are having or why. What it can do is lay out the explanations worth discussing with your prescriber or GP.
What the regulators found
Reports of low mood and suicidal thoughts in people using GLP-1 medicines prompted formal safety reviews in 2023. The European Medicines Agency’s safety committee concluded in April 2024 that the available evidence did not support a causal association between GLP-1 receptor agonists and suicidal or self-injurious thoughts and actions.[4] The MHRA reached the same conclusion for the UK in September 2024, extending it to depression, and said no change to the product information was warranted while it continued to monitor.[3]
Two caveats. First, both reviews examined exenatide, lixisenatide, liraglutide, dulaglutide and semaglutide. Mounjaro’s active ingredient, tirzepatide, acts on the GLP-1 receptor too, but it was not named in those reviews. Second, an absence of proven causation is not proof of no effect for every individual; that is why the regulators keep watching, and why a pharmacovigilance analysis published in 2026 still found depression, anxiety and suicidal ideation among the most frequently reported psychiatric events for this class while noting that regulators have not confirmed a causal relationship.[5] If you think Mounjaro has affected your mood, you can report it through the MHRA Yellow Card scheme, which is exactly how these signals are picked up.[6]
Possible explanations for feeling flat
These are not diagnoses. They are the things a prescriber or GP is likely to consider, and it is common for more than one to apply.
Food was doing more than feeding you
For many people, eating is comfort, reward, celebration and a way of getting through a hard day. Mounjaro removes much of the drive to eat and, for some, the pleasure of it. If food was your main source of reward, losing it can leave a gap that feels like flatness until other sources of pleasure fill it. Our emotional eating guide covers this in depth.
You may be eating too little
Very low intake leaves the body short of energy and the brain short of fuel. The result can be low motivation, poor concentration and a blunted mood that is really under-eating. Skipping meals because you are not hungry, rather than eating small regular amounts, is one of the most common patterns on treatment. See eating well on Mounjaro.
Fatigue and poor sleep
Tiredness is a listed side effect of Mounjaro,[1] and persistent tiredness can be hard to separate from low mood. Disturbed sleep, whether from reflux, needing the toilet or simply a changed routine, compounds it. Read why you feel tired on Mounjaro.
Alcohol has dropped away
Many people find they want to drink less on Mounjaro. If evenings used to be structured around a drink, the absence can feel like a loss even when it is good for you. See Mounjaro and alcohol.
The change itself
Rapid weight loss changes how you look, how people treat you, how clothes fit and how you think about yourself. Big changes, even wanted ones, take emotional adjustment. Some people also carry the weight of other people’s comments; our stigma guide is written for that.
Something unrelated
Low mood and anhedonia have many causes that have nothing to do with a weight-loss medicine: thyroid problems, low iron or vitamin levels, other medicines, life events, and depression itself. Starting a new treatment does not make these less likely. This is why a GP review matters if the feeling persists.
What you can do next
- Keep a two-week note of mood out of 10, what you ate, how you slept and whether the flatness is about food only or wider.
- Eat regularly even without appetite. Small meals with protein at each one are the usual advice; a prescriber or dietitian can tailor it.
- Rebuild reward deliberately. Plan things that used to give you pleasure that are not food, and notice whether they still land.
- Talk to your prescriber and tell them exactly what you have noticed and when it started relative to your doses. They can review dose, titration pace, nutrition and other medicines.
- See your GP if the flatness is persistent, spreading beyond food, or affecting work, relationships or sleep. NHS talking therapies can be self-referred without a GP.[7]
Do not stop or change your prescribed dose on your own to test the theory. A prescriber can help you do that safely if it is the right call.
A message you can copy and adapt for your prescriber:
“Since starting Mounjaro I have noticed a flat or low feeling. It started [when] and is [about food only / more general]. I am eating [roughly what and how often] and sleeping [how]. Could you advise whether my dose, nutrition or anything else could be contributing, and whether I should see my GP?”
When to get help now
Call 999 or go to A&E if you have harmed yourself, or feel you may act on thoughts of harming yourself.
Get same-day support if you are having thoughts of self-harm or suicide, even if you would not act on them: call NHS 111 and choose the mental health option, contact your GP for an urgent appointment, or call Samaritans on 116 123 free at any hour.[8]
Tell whoever you speak to that you are taking Mounjaro. It may or may not be relevant, but it is part of the picture.
Common questions
Is anhedonia a known side effect of Mounjaro?
No. It is not listed in the UK patient leaflet or the Summary of Product Characteristics. People do report a flat feeling, particularly around food, and reports are how regulators monitor safety, but it is not a recognised adverse effect at present.
Does Mounjaro cause depression?
Regulators in the UK and Europe reviewed GLP-1 medicines in 2023 and 2024 and concluded the evidence does not establish a causal link with depression, suicidal thoughts or self-harm. Those reviews did not name tirzepatide specifically, and monitoring continues. If your mood has changed, take it seriously and speak to your GP regardless of the cause.
Why does food not give me any pleasure any more?
Mounjaro reduces appetite and, for many people, the pull towards food. If eating was also comfort or reward, losing that can feel like a loss until other sources of enjoyment replace it. Eating too little can make everything feel flatter as well.
Will it pass?
Many people say the food-related flatness settles as they adjust and find new routines, but there is no reliable evidence on timing and no guarantee. A flat feeling that persists, spreads beyond food or worsens should be reviewed rather than waited out.
Should I stop Mounjaro if I feel flat?
Not on your own. Speak to your prescriber, who can look at dose, pace, nutrition and other causes, and to your GP if the feeling is persistent. If you and your clinicians decide a pause or a change is right, they can guide it.
Related guides
About this page. Monj is an independent information and price comparison service run by Medstack Ltd. It is not a pharmacy and does not prescribe, dispense or sell medicines. This page provides general information, not diagnosis or individual medical advice, and it does not diagnose depression, anhedonia or any other condition. It has not been clinically reviewed; a named clinical reviewer will be added when one has approved it. What is known: anhedonia is not a listed side effect, and regulators found no causal link between GLP-1 medicines and depression or suicidality. What is uncertain: whether tirzepatide affects mood in some individuals, which regulators continue to monitor. Where professional judgement is required: the cause of your symptoms and any change to treatment. Read our editorial and review policy and independence statement.
References
- Eli Lilly. Mounjaro KwikPen: Package leaflet, information for the patient (UK), revised August 2026. electronic medicines compendium. medicines.org.uk/emc/product/15481/pil. Accessed 6 September 2026.
- Eli Lilly. Mounjaro KwikPen: Summary of Product Characteristics (UK). electronic medicines compendium. medicines.org.uk/emc/product/15481/smpc. Accessed 6 September 2026.
- MHRA. MHRA finds evidence does not support a link between Glucagon-Like Peptide-1 (GLP-1) receptor agonists and suicidal and self-injurious thoughts and actions. GOV.UK, September 2024. gov.uk. Accessed 6 September 2026.
- European Medicines Agency. Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC), 8 to 11 April 2024. ema.europa.eu. Accessed 6 September 2026.
- Reporting patterns of suicide- and self-injury-related events involving liraglutide, semaglutide, and tirzepatide: data from the European pharmacovigilance database. Frontiers in Pharmacology. 2026. frontiersin.org. Accessed 6 September 2026.
- MHRA. Yellow Card scheme. yellowcard.mhra.gov.uk. Accessed 6 September 2026.
- NHS. Find an NHS talking therapies service. nhs.uk. Accessed 6 September 2026.
- NHS. Where to get urgent help for mental health. nhs.uk. Accessed 6 September 2026.
Explore other side effects
Tap a point on the body to jump to that symptom, or choose from the full list below. The pink marker shows where you are now.
© 2026 Medstack Ltd. Written and published by Monj (monj.co.uk). You are welcome to link to this page or quote a short extract with a credit and a link. Republishing the text, page structure, safety-routing design or price data, in whole or in part, including to train or ground an automated system, is not permitted without written permission. See our independence statement and editorial and review policy.